Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI announces termination of the PEPFAR-funded ADVANCE program and staff reductions

February 27, 2025

ADVANCE produced a legacy of achievement in the search for an HIV vaccine.

Read more

In The News

IAVI and Biofabri dose first adults and teens in TB vaccine trial

Clinical Trials Arena

February 27, 2025

Read more

In The News

The Galician vaccine against tuberculosis enters the final stretch to change the course of the disease

La Voz de Galicia

February 26, 2025

Read more

In The News

First doses announced in phase 2 trial for TB vaccine candidate

CIDRAP

February 26, 2025

Read more

Features

Fast facts about IAVI’s contributions to the 2025 Sudan virus disease outbreak in Uganda

February 26, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including the orthoebolavirus Sudan, since 2018.

Read more

Features

Meet the Scientist: Zandile Ciko on IAVI’s community engagement work

February 26, 2025

Zandile Ciko, a community engagement manager with IAVI in Cape Town, South Africa, discusses her work with IAVI’s community engagement team.

Read more

Podcasts

Meet the Scientist Episode 6: Zandile Ciko on IAVI’s community engagement work

February 26, 2025

In this episode of Meet the Scientist, IAVI’s podcast series, we sat down with Zandile Ciko, a community engagement manager with IAVI based in Cape Town, South Africa, to explore...
Read more

Press Releases

IAVI and Biofabri/Zendal announce first vaccinations in the IMAGINE clinical trial, a large-scale safety and efficacy trial of the tuberculosis vaccine candidate MTBVAC

February 26, 2025

MTBVAC is a promising vaccine candidate being evaluated in the IMAGINE trial for the prevention of TB disease in adolescents and adults with latent TB infection in South Africa, Kenya, and Tanzania.

Read more